PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study finds patients AFib at higher risk of dementia when meds out of range

Study included 2,600 AFib patients

2014-05-10
(Press-News.org) A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City has found that atrial fibrillation patients who are on blood thinning medications are at higher risk of developing dementia if their doses are not in the optimal recommended range.

The study of more than 2,600 AFib patients found they are significantly more likely to develop dementia when using medicines to prevent blood clots, such as warfarin, when their dosing is too high or too low for an extended period of time.

Findings from the study will be presented at the 2014 Annual Heart Rhythm Society Scientific Session on Friday, May 9, 2014, at 6:30 pm, EDT, in San Francisco.

In the United States, nearly one in 10 people, or about 2.7 million Americans, develop AFib in their lifetimes. Atrial fibrillation is a quivering or irregular heartbeat that can lead to blood clots, stroke, heart failure and other heart-related complications.

Physicians try to achieve an international normalized ratio (a test used to learn how fast the blood clots) of two to three, which is within the therapeutic range, or the safety range. Typically, dosages higher than the therapeutic range can increase the risk of bleeding. If the dose is lower than the therapeutic range, it can increase risk of blood clots forming.

Three years ago researchers at the Intermountain Medical Center Heart Institute found that patients with atrial fibrillation were at higher risk for developing dementia, but the cause of that association — the link between anticoagulation medication and dementia — was unknown.

"Most patients who develop atrial fibrillation require the use of an anticoagulant to prevent a stroke. The most common anticoagulant used worldwide is warfarin, and we now know that if warfarin doses are consistently too high or too low, one of the long-term consequences can be brain damage," said Jared Bunch, MD, lead author and director of electrophysiology research at the Intermountain Medical Center Heart Institute. "This points to the possibility that dementia in atrial fibrillation patients is partly due to small repetitive clots and/or bleeds in the brain."

Results from the Intermountain Medical Center Heart Institute study were collected from 2,693 patients, with 4.1 percent of them being diagnosed with dementia. Results were based on the percentage of time their blood-thinning medications were within the range. The more time their dosages were within the range, the less risk they had of developing dementia. Specifically:

Patients within the therapeutic range less than 25 percent of the time were 4.5 times more likely to develop dementia.

Patients within the therapeutic range 25-50 percent of the time were 4.1 times more likely to develop dementia.

Patients within the therapeutic range 51-75 percent were only 2.5 percent more likely to develop dementia.

The increased risk remained significant when adjusting for common risks of both stroke and bleeding, noted Dr. Bunch.

"Our results from the study tell us two things," he said. "With careful use of anticoagulation medications, the dementia risk can be reduced. Patients on warfarin need very close follow-up in specialized anticoagulation centers if possible to ensure their blood levels are within the recommended levels more often.

"Second, these results also point to a potential new long-term consequence of dependency on long-term anticoagulation medications. In this regard, stroke prevention therapies do not require long-term anticoagulation medications and reducing the use of these drugs will hopefully lower dementia risk."

Dementia is cognitive dysfunction that impacts quality of life. Dementia is a progressive disease, and the impact on quality of life often worsens not only for patients, but also for their families and loved ones.

Warfarin is used to prevent blood clots in atrial fibrillation patients, and though it is an effective therapy, the drug poses risks if improperly dosed. Proper dosing of warfarin is complicated because the drug interacts with many other common medications, as well as some foods.

When determining an initial dose of warfarin, physicians often start with a standard dose and can take certain clinical indicators into account to alter that dose. These clinical measures include age, body size, smoking status, and use of certain medications. During the initial weeks of therapy, the warfarin activity is monitored closely through blood tests, and adjustments are made as needed.

INFORMATION: END


ELSE PRESS RELEASES FROM THIS DATE:

Bee biodiversity boosts crop yields

Bee biodiversity boosts crop yields
2014-05-10
Research from North Carolina State University shows that blueberries produce more seeds and larger berries if they are visited by more diverse bee species, allowing farmers to harvest significantly more pounds of fruit per acre. "We wanted to understand the functional role of diversity," says Dr. Hannah Burrack, an associate professor of entomology at NC State and co-author of a paper on the research. "And we found that there is a quantifiable benefit of having a lot of different types of bees pollinating a crop." The researchers looked at blueberries in North Carolina ...

Scientists find gene behind a highly prevalent facial anomaly

2014-05-10
CAMBRIDGE, Mass. (May 9, 2014) – Whitehead Institute scientists have identified a genetic cause of a facial disorder known as hemifacial microsomia (HFM). The researchers find that duplication of the gene OTX2 induces HFM, the second-most common facial anomaly after cleft lip and palate. HFM affects approximately one in 3,500 births. While some cases appear to run in families, no gene had been found to be causative. That is until Whitehead Fellow Yaniv Erlich and his lab set out to do just that. Their work is described in this week's issue of the journal PLOS ONE. Patients ...

Cardiac screening test may help determine who should take aspirin to prevent heart attack

2014-05-09
MINNEAPOLIS, MN – May 6, 2014 – For over 30 years, aspirin has been known to prevent heart attacks and strokes, but who exactly should take a daily aspirin remains unclear. New research published today in Circulation: Cardiovascular Quality and Outcomes shows that your coronary artery calcium (CAC) score, a measurement of plaque in the arteries that feed the heart, may help determine whether or not you are a good candidate for aspirin. "Many heart attacks and strokes occur in individuals who do not appear to be at high risk," states lead author, Michael D Miedema, MD, ...

NASA's TRMM Satellite see spring storms hit the US Great Plains

NASAs TRMM Satellite see spring storms hit the US Great Plains
2014-05-09
VIDEO: The TRMM satellite flew above tornado spawning thunderstorms in the southern United States on May 9, 2014 at 0115 UTC. This simulated 3-D TRMM animation shows the location of intense... Click here for more information. The Tropical Rainfall Measuring Mission or TRMM satellite captured rainfall and cloud height information about the powerful thunderstorms and severe weather that affected the Great Plains over May 8 and 9. Severe weather extended from Minnesota to southern ...

Plugging leaky blood vessels to save vision

2014-05-09
TORONTO – A new drug approach has been developed for safer clean-up of deformed blood vessels in the eye by a research team at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto. The growth of malformed blood vessels that can burst is a leading cause of vision loss in North America. Retinopathy and retina degeneration are associated with premature birth, with diabetes, and with increasing age. Research just published by Dr. Andras Nagy and co-authors shows both safety and effectiveness in their bioengineered compound when treating retinopathy ...

Paleontologists discover new fossil organism

Paleontologists discover new fossil organism
2014-05-09
RIVERSIDE, Calif. — Scientists at the University of California, Riverside have discovered a fossil of a newly discovered organism from the "Ediacara Biota" — a group of organisms that occurred in the Ediacaran period of geologic time. Named Plexus ricei and resembling a curving tube, the organism resided on the Ediacaran seafloor. Plexus ricei individuals ranged in size from 5 to 80 centimeters long and 5 to 20 millimeters wide. Along with the rest of the Ediacara Biota, it evolved around 575 million years ago and disappeared from the fossil record around 540 million ...

Discovery links rare, childhood neurodegenerative diseases to common problem in DNA repair

2014-05-09
(MEMPHIS, Tenn. – May 9, 2014) St. Jude Children's Research Hospital scientists studying two rare, inherited childhood neurodegenerative disorders have identified a new, possibly common source of DNA damage that may play a role in other neurodegenerative diseases, cancer and aging. The findings appear in the current issue of the scientific journal Nature Neuroscience. Researchers showed for the first time that an enzyme required for normal DNA functioning causes DNA damage in the developing brain. DNA is the molecule found in nearly every cell that carries the instructions ...

Longevity gene may boost brain power

2014-05-09
Scientists showed that people who have a variant of a longevity gene, called KLOTHO, have improved brain skills such as thinking, learning and memory regardless of their age, sex, or whether they have a genetic risk factor for Alzheimer's disease. Increasing KLOTHO gene levels in mice made them smarter, possibly by increasing the strength of connections between nerve cells in the brain. The study was partly funded by the National Institutes of Health. "This could be a major step toward helping millions around the world who are suffering from Alzheimer's disease and ...

Autism-related protein shown to play vital role in addiction

2014-05-09
BELMONT - In a paper published in the latest issue of the neuroscience journal Neuron, McLean Hospital investigators report that a gene essential for normal brain development, and previously linked to Autism Spectrum Disorders, also plays a critical role in addiction-related behaviors. "In our lab, we investigate the brain mechanisms behind drug addiction – a common and devastating disease with limited treatment options," explained Christopher Cowan, PhD, director of the Integrated Neurobiology Laboratory at McLean and an associate professor of Psychiatry at Harvard Medical ...

Quick test can help spot depressed teenagers, UT Arlington nursing researcher finds

Quick test can help spot depressed teenagers, UT Arlington nursing researcher finds
2014-05-09
A few minutes spent filling out a widely accepted mental health assessment in a health care provider's waiting room could make a big difference for some teenagers suffering from depression, according to new study from a nursing researcher at The University of Texas at Arlington. Sharolyn Dihigo, a nurse practitioner and clinical assistant professor in the UT Arlington College of Nursing, recently examined available research to determine whether nurse practitioners and others in primary care settings should add a mental health screening to well visits for teenage patients. ...

LAST 30 PRESS RELEASES:

Most advanced artificial touch for brain-controlled bionic hand

Compounding drought and climate effects disrupt soil water dynamics in grasslands

Multiyear “megadroughts” becoming longer and more severe under climate change

Australopithecines at South African cave site were not eating substantial amounts of meat

An AI model developed to design proteins simulates 500 million years of protein evolution in developing new fluorescent protein

Fine-tuned brain-computer interface makes prosthetic limbs feel more real

New chainmail-like material could be the future of armor

The megadroughts are upon us

Eavesdropping on organs: Immune system controls blood sugar levels

Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors

New study reveals how climate change may alter hydrology of grassland ecosystems

Polymer research shows potential replacement for common superglues with a reusable and biodegradable alternative 

Research team receives $1.5 million to study neurological disorders linked to long COVID

Research using non-toxic bacteria to fight high-mortality cancers prepares for clinical trials

Do parents really have a favorite child? Here’s what new research says

Mussel bed surveyed before World War II still thriving

ACS Annual Report: Cancer mortality continues to drop despite rising incidence in women; rates of new diagnoses under 65 higher in women than men

Fewer skin ulcers in Werner syndrome patients treated with pioglitazone

Study finds surprising way that genetic mutation causes Huntington’s disease, transforming understanding of the disorder

DNA motors found to switch gears

Human ancestor thrived longer in harsher conditions than previous estimates

Evolution: Early humans adapted to extreme desert conditions over one million years ago

Race and ethnicity and diffusion of telemedicine in Medicaid for schizophrenia care after onset of the COVID-19 pandemic

Changes in support for advance provision and over-the-counter access to medication abortion

Protein level predicts immunotherapy response in bowel cancer

The staying power of bifocal contact lens benefits in young kids

Dose-dependent relationship between alcohol consumption and the risks of hepatitis b virus-associated cirrhosis and hepatocellular carcinoma: A meta-analysis and systematic review

International Alliance for Primary Immunodeficiency Societies selects Rockefeller University Press to publish new Journal of Human Immunity

Leader in mission-driven open publishing wins APE Award for Innovation in Scholarly Communication

Innovative 6D pose dataset sets new standard for robotic grasping performance

[Press-News.org] Study finds patients AFib at higher risk of dementia when meds out of range
Study included 2,600 AFib patients